Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
15 May 24
SC 13G/A
IO Biotech, Inc.
14 May 24
4
IO Biotech, Inc.
14 May 24
144
IO Biotech, Inc.
10 May 24
SC 13D/A
SPRUCE BIOSCIENCES, INC.
28 Mar 24
SC 13D/A
SPRUCE BIOSCIENCES, INC.
25 Mar 24
4
SPRUCE BIOSCIENCES, INC.
25 Mar 24
SC 13D/A
SPRUCE BIOSCIENCES, INC.
20 Mar 24
4
SPRUCE BIOSCIENCES, INC.
20 Mar 24
144
SPRUCE BIOSCIENCES, INC.
18 Mar 24
SC 13D/A
SPRUCE BIOSCIENCES, INC.
18 Mar 24
4
SPRUCE BIOSCIENCES, INC.
18 Mar 24
144
SPRUCE BIOSCIENCES, INC.
14 Mar 24
SC 13D/A
LAVA Therapeutics NV
7 Mar 24
4
Metagenomi, Inc.
15 Feb 24
SC 13G/A
Evotec SE
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13D/A
IO Biotech, Inc.
13 Feb 24
4
IO Biotech, Inc.
13 Feb 24
144
IO Biotech, Inc.
9 Feb 24
3
Metagenomi, Inc.
8 Feb 24
SC 13D/A
Edgewise Therapeutics, Inc.
25 Jan 24
SC 13G/A
Rallybio Corp
2 Jan 24
SC 13D/A
Reneo Pharmaceuticals, Inc.
15 Dec 23
SC 13G/A
Lexeo Therapeutics, Inc.
15 Dec 23
SC 13G
Lexeo Therapeutics, Inc.
24 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
SC 13D/A
LAVA Therapeutics NV
9 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
SC 13D/A
IO Biotech, Inc.
11 Aug 23
4
IO Biotech, Inc.
11 Aug 23
SC 13D/A
Cyteir Therapeutics, Inc.
3 Aug 23
SC 13D/A
Cyteir Therapeutics, Inc.
26 Jul 23
4
Cyteir Therapeutics, Inc.
20 Jul 23
4
Cyteir Therapeutics, Inc.
18 Jul 23
144
Cyteir Therapeutics, Inc.
14 Jul 23
4
Cyteir Therapeutics, Inc.
3 Jul 23
4
Cyteir Therapeutics, Inc.
28 Jun 23
SC 13G/A
Disc Medicine, Inc.
28 Jun 23
4
Disc Medicine, Inc.
28 Jun 23